Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: APOP, MARK, OSTK, VKTX

Published 01/05/2018, 12:53 AM
Updated 07/09/2023, 06:31 AM

Cellect Biotechnology Ltd. (NASDAQ:APOP) exploded on some really big news, jumping 2.69, or 38%, to 9.81, on 3.8 million shares traded on Thursday. The last time it exploded was last Jan, then Feb, Mar, Aug, Oct, and now. Every time it exploded, it pulled back, and it might very well do that again. It had a terrible close, and I don’t know where to put a stop on it. I’m going to look at 8.75-9 as a very important support level. If it manages to back and fill, and move back up again, my targets will be 13 1/2, and then 17. Those are possibilities in my opinion, and what I will be looking for going forward.

Remark Holdings, Inc. (NASDAQ:MARK) ran 47 cents, or 4.47%, to 10.98, on 2.4 million shares traded on Thursday, and didn’t close great, but had an up-day for the third day in a row. It ran up to the ascending topsline and backed off. I still think it’s going to form a rising wedge that’s going to explode to the upside, and hit the 15 and 19-20 range. Keep and eye on this one.

Overstock.com, Inc. (NASDAQ:OSTK) did well despite the fact that most formulated and related stocks did not do well on Thursday. It ran 6.25, or 8.78%, to 77.80, with a high of 78.32, on 7.4 million shares traded. That’s the best volume on an up-day in two or three weeks. It’s breaking out of the wedge. Now I’m looking for a test, and to take out 82.70 on Friday, and then 95.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Viking Therapeutics, Inc. (NASDAQ:VKTX) is doing great and I’m really liking the way it is acting coming out of a flag. It was up 17 cents, or 3.52%, to 5.00, on 1.1 million shares traded. Next, I’m looking for it to get up to the 5-5.20 range, and then my targets are 6, and 7 going forward.

On the long side, stocks included Cellect Biotechnology Ltd. (NASDAQ:APOP), Audentes Therapeutics, Inc. (NASDAQ:BOLD), Cheetah Mobile Inc. (NYSE:CMCM), California Resources Corporation (NYSE:CRC), CARBO Ceramics Inc. (NYSE:CRR), Emerge Energy Services (NYSE:EMES), U.S. Silica Holdings, Inc. (NYSE:SLCA), Extreme Networks, Inc. (NASDAQ:EXTR), Fate Therapeutics, Inc. (NASDAQ:FATE), Fiat Chrysler Automobiles N.V. (NYSE:FCAU), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Kirkland Lake Gold Ltd. (TO:KL), Kopin Corporation (NASDAQ:KOPN), Remark Holdings, Inc. (MARK), NewLink Genetics Corporation (NASDAQ:NLNK), Overstock.com, Inc. (OSTK), Viking Therapeutics, Inc. (NASDAQ:VKTX), W&T Offshore Inc. (NYSE:WTI), Xunlei Limited (NASDAQ:XNET), and Zumiez, Inc. (NASDAQ:ZUMZ).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.